Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anqing Lv
Blocking Mammalian Target of Rapamycin Alleviates Bone Cancer Pain and Morphine Toleranceviaµ-Opioid Receptor
International Journal of Cancer
Cancer Research
Oncology
Related publications
Neuron-Restrictive Silencer Factor–mediated Downregulation of Μ-Opioid Receptor Contributes to the Reduced Morphine Analgesia in Bone Cancer Pain
Pain
Neurology
Anesthesiology
Pain Medicine
Pharmacology
Effects of Intraperitoneal and Intrathecal Morphine Analgesia on the Expression of Μ-Opioid Receptors in Bone Cancer Pain Rats
Dose-Response
Chemical Health
Mutagenesis
Public Health
Environmental
Safety
Toxicology
Health
Occupational Health
Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)
Science-Business eXchange
Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging
Annals of the American Thoracic Society
Pulmonary
Respiratory Medicine
Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin
Clinical Cancer Research
Cancer Research
Oncology
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain
Journal of Pain
Neurology
Anesthesiology
Pain Medicine
Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells
Cancer Research
Cancer Research
Oncology
New Targets for Therapy in Breast Cancer: Mammalian Target of Rapamycin (mTOR) Antagonists
Breast Cancer Research
Cancer Research
Oncology
